With a singular goal to improve patient lives, Hyku is pioneering precise covalent targeting of disease-causing proteins and transforming conventional treatment paradigms

Biotechnology

Life Sciences

Therapeutics

Hyku Biosciences

Hyku Biosciences' headquarters in Lexington, United States

Kleem Chaudhary

Andrea Zuhl

Keith Wilcoxen

Laura Brass

Kou Qin

The Corporate Strategy and Investment team at Hyku Biosciences is responsible for identifying and evaluating strategic partnerships and investment opportunities that align with the company's mission to enhance patient outcomes. This team conducts in-depth market analysis, fosters relationships with potential collaborators, and supports the development of long-term growth strategies to advance innovative therapies in precise covalent targeting.

Corporate Strategy and Investment

The Leadership Team at Hyku Biosciences is responsible for setting the strategic direction of the company, guiding research and development efforts, and fostering partnerships to advance innovative therapies. Comprising experts in biology, chemistry, and venture investments, this team collaborates to ensure that projects align with the goal of enhancing patient lives through precise covalent targeting of disease-causing proteins.

Leadership Team

The Scientific Research and Development team at Hyku Biosciences is dedicated to pioneering innovative approaches for precise covalent targeting of disease-related proteins. Comprised of experts in biology, chemistry, and proteomics, the team focuses on developing and validating cutting-edge therapeutic strategies that aim to transform treatment paradigms and enhance patient outcomes in various diseases, particularly cancer.

Hyku Biosciences

Org chart

Teams

Corporate Strategy and Investment

Leadership Team

Scientific Research and Development

Offices

Hyku Biosciences

Org chart

Teams

Corporate Strategy and Investment

Leadership Team

Scientific Research and Development

Offices

Related companies